Trial Profile
peginterferon alfa-2b and ribavirin plus pitavastatin for chronic hepatitis type C : A pilot study
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 03 Jul 2012
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2b (Primary) ; Pitavastatin (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 28 Jun 2012 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 29 Dec 2008 New trial record.